Vamlodip Tablets | Advanced Antihypertensive Combination Therapy for Blood Pressure Control

Vamlodip Tablets are a clinical-grade prescription cardiovascular medication formulated with a synergistic combination of Valsartan and Amlodipine. Designed for comprehensive blood pressure management, this dual-action oral therapy is prescribed for patients with essential hypertension who require more effective blood pressure reduction than a single agent can provide, or as initial therapy when rapid control is clinically necessary.

Key Benefits:

• Combines an angiotensin II receptor blocker (ARB) and a calcium channel blocker (CCB) for enhanced, multi-pathway blood pressure control

• Provides sustained, 24-hour hemodynamic stability and reduces cardiovascular morbidity and mortality risks

• Helps prevent critical vascular complications associated with chronic hypertension, such as stroke, heart attack, and renal damage

• Dual-mechanism formulation allows for optimized blood pressure regulation with balanced tolerability

• Convenient oral tablet format designed for once-daily clinical management under medical supervision

How It Works: Vamlodip features two distinct, complementary mechanisms of action. Valsartan is an angiotensin II receptor blocker (ARB) that selectively blocks the vasoconstricting and aldosterone-secreting effects of angiotensin II, leading to smooth blood vessel dilation and reduced vascular resistance. Amlodipine is a dihydropyridine calcium channel blocker (CCB) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle cells, causing peripheral arterial vasodilation and lowering blood pressure.

Directions for Use: Take tablets orally once daily with a full glass of water, with or without food, exactly as prescribed by your physician or healthcare professional. Swallow the tablets whole; do not crush, chew, or split them. Maintain a consistent daily administration schedule for optimal therapeutic efficacy.

Precautions:

• For oral prescription use only. Keep out of reach of children.

• Contraindicated in patients with hypersensitivity to valsartan, amlodipine, or other dihydropyridine derivatives, and in pregnant women due to the risk of fetal toxicity during the second and third trimesters.

• Do not co-administer aliskiren-containing products with Vamlodip in patients with diabetes mellitus.

• Use with caution in patients with severe aortic stenosis, heart failure, impaired hepatic or renal function, or volume/sodium depletion.

• May cause dizziness, hypotension, or peripheral edema; exercise caution when driving or operating machinery.

• Discontinue use and seek immediate medical advice if pregnancy is detected or if you experience severe allergic reactions, swelling of the face/lips, or symptoms of low blood pressure.

Storage Instructions: Store in a cool, dry place away from direct sunlight, excessive heat, and moisture (do not store above 30°C). Keep the container tightly closed when not in use.

Manufacturer Information: Please refer to the product packaging for the latest manufacturer, formulation, batch, and registration details. All pharmaceuticals are manufactured in facilities adhering to stringent international quality control standards.

Manage your blood pressure effectively and protect your cardiovascular health with Vamlodip Tablets. Experience reliable multi-pathway hemodynamic support under professional clinical supervision. Add this essential prescription treatment to your care plan under medical guidance.